ASN
AIM

Advisory Services Network’s AIM ImmunoTech AIM Stock Holding History

Advisory Services Network’s Portfolio AIM Stock Details AIM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q4 		– Sell
-13
Closed -$3K – 3979
2020
Q3 		$3K Buy
+13
New +$3.25K ﹤0.01% 3055
2020
Q2 		– Sell
-125
Closed -$32K – 3195
2020
Q1 		$32K Buy
+125
New +$19.6K ﹤0.01% 1615

Other funds holding AIM

Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
BCM
Bridgeway Capital Management Houston, Texas $4.97B AUM 44.96% 1-Year Est. Return
VF
Virtu Financial New York $2.41B AUM 48.35% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Verition Fund Management
Verition Fund Management Greenwich, Connecticut $15.4B AUM 30.69% 1-Year Est. Return
SWM
SeaCrest Wealth Management Purchase, New York $903M AUM 47.26% 1-Year Est. Return

Advisory Services Network's AIM Position: Q4 2020 in Review

Advisory Services Network sold out of AIM ImmunoTech (AIM) in Q4 2020, closing a stake of 13 shares — an estimated $3K sold.

Advisory Services Network first reported a position in AIM in Q1 2020 and held it in 2 quarters. The position peaked at $32K in Q1 2020. 33 funds tracked by Wall St. Rank hold AIM as of Q4 2020.

  • Advisory Services Network reported no remaining AIM ImmunoTech position as of Q4 2020 after selling out during the quarter.
  • Advisory Services Network sold 13 AIM ImmunoTech shares in Q4 2020, an estimated $3K.
  • Advisory Services Network first reported a position in AIM ImmunoTech in Q1 2020 and held it in 2 quarters.
  • Advisory Services Network's AIM ImmunoTech position peaked at $32K in Q1 2020.
  • 33 funds tracked by Wall St. Rank held AIM ImmunoTech as of Q4 2020.

Based on Advisory Services Network's 13F filing for Q4 2020, filed 9 Feb 2021.